Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Drug Resistance
100%
Cancer Stem Cells
50%
Tumor
25%
Epigenetics
25%
Signaling Pathway
25%
In Cancer
25%
Disease Progression
25%
Clinical Evidence
25%
Tumor Cells
25%
Tumor Heterogeneity
25%
Resistance Mechanisms
25%
Overcoming Resistance
25%
Response to Therapy
25%
Stem Cells
25%
Targeted Agents
25%
Tumor Microenvironment
25%
Tumor Recurrence
25%
Notch Signaling
25%
Heterogeneous Population
25%
Self-renewal
25%
Cell Signaling Pathways
25%
Non-squamous
25%
Genetic Characteristics
25%
Radiotherapy Resistance
25%
Pro-survival
25%
Tumor Disease
25%
Chemoresistance
25%
Stem Cell Maintenance
25%
Notch Pathway
25%
Multilineage Differentiation
25%
Therapeutic Failure
25%
Intrinsic Mechanism
25%
Intrinsic Influence
25%
Drug Transporters
25%
Phenotypic Characteristics
25%
Tumor-initiating
25%
Anti-apoptotic Pathways
25%
Resistant Clones
25%
Diverse Response
25%
Cell-intrinsic
25%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Drug Resistance
100%
Neoplasm
66%
Stem Cell
66%
Cancer Stem Cell
66%
Malignant Neoplasm
33%
Signal Transduction
33%
Lung Cancer
33%
Recurrent Disease
33%
Radiation Therapy
33%
Tumor Cell
33%
Disease Exacerbation
33%
Antiapoptotic
33%
Tumor Recurrence
33%
Tumour Heterogeneity
33%
Tumor Microenvironment
33%
INIS
cancer
100%
drugs
100%
notches
100%
lung cells
100%
tumors
71%
stem cells
57%
diseases
14%
lungs
14%
therapy
14%
populations
14%
radiotherapy
14%
failures
14%
genetics
14%
maintenance
14%
tumor cells
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Non Small Cell Lung Cancer
100%
Drug Resistance
100%
Malignant Neoplasm
75%
Lung Cancer
25%
Recurrent Disease
25%
Disease Exacerbation
25%
Tumor Recurrence
25%
Antiapoptotic
25%
Tumor Microenvironment
25%
Immunology and Microbiology
Stem Cell
100%
Drug Resistance
100%
Cancer Stem Cell
100%
Signal Transduction
50%
Tumor Cell
50%
Lineages
50%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Cancer Stem Cell
100%
Drug Resistance
100%
Genetics
50%
Epigenetics
50%
Signal Transduction
50%